Doctors must actively participate in the Pharmacovigilance Programme of India


eMediNexus    03 February 2023

If a patient suffers an adverse drug reaction while on treatment, the doctor is required to disclose the information under the Pharmacovigilance Programme of India.


If there is any suspicion that an adverse event or an adverse reaction has occurred, the healthcare professional attending to the patient can report the adverse drug reactions (ADR) in a prescribed form to the ADRs Monitoring Centers under the Pharmacovigilance Programme of India (PvPI).


Only the patient’s initials have to be filled in the ADR form and all the patient details are kept confidential. The form can be downloaded from the websites of Indian Pharmacopoeia Commission (www.ipc.gov.in) or Central Drugs Standard Control Organization (CDSCO) (www.cdsco.nic.in).

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.